Literature DB >> 4583583

Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.

M D Parker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4583583

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  22 in total

1.  Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases.

Authors:  M Abu-Shakra; M Krup; H Slor; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.

Authors:  D M Grennan; C Bunn; G R Hughes; W W Buchanan; W C Dick
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

Review 3.  Antinucleic acid antibodies.

Authors:  E J Holborow
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

4.  The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies.

Authors:  M Abu-Shakrah; M Krupp; S Argov; D Buskila; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.

Authors:  M D Parker; G P Kerby
Journal:  Ann Rheum Dis       Date:  1974-09       Impact factor: 19.103

6.  Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).

Authors:  A Gaudreau; B Amor; M F Kahn; A Ryckewaert; J Sany; A P Peltier
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

7.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

8.  Clinical significance of antibodies to ribonucleoprotein.

Authors:  M L Cohen; B Dawkins; R L Dawkins; E T Owen
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

9.  [The value of RNase-ANA determinations for the diagnosis of Sharp syndrome (mixed connective tissue disease) (author's transl)].

Authors:  M Rosenthal
Journal:  Klin Wochenschr       Date:  1977-01-01

10.  Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.

Authors:  M Zouali; A Eyquem
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.